# Ajanta Pharma Ltd. - Inspection Records

Source: https://www.keypedia.com/companies/ajanta-pharma-ltd/040efb87-46b2-4747-b87d-c1d87daad1e7

> Inspection records and compliance data for Ajanta Pharma Ltd. in Aurangabad, None. Access full analysis and detailed observations.

---

## Details

- Name: Ajanta Pharma Ltd.
- FEI Number: 3006785788
- City: Aurangabad
- State: None
- Country Name: India
- Address Line 1: B-4/5/6 MIDC Industrial Area, Paithan
- Zip Code: None
- Business Operations: FDF MANUFACTURE

## Related Documents

- [483 - Ajanta Pharma Ltd. - 2026-04-21](https://www.keypedia.com/records/483/ajanta-pharma-ltd/0e2e1c27-f6e4-4890-be38-fd6f38fc3be6) — source: FDA, date: April 21, 2026
- [FDA Inspection 1313426 - Ajanta Pharma Ltd. - 2026-04-21](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/6118c3f9-60aa-44a4-ae82-113ff53e50a0) — source: FDA, date: April 21, 2026
- [FDA Inspection 1235564 - Ajanta Pharma Ltd. - 2024-03-05](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/569ea093-1787-4fef-a865-1ddc3c6fa809) — classification: No Action Indicated (NAI), source: FDA, date: March 5, 2024
- [483 - Ajanta Pharma Ltd. - 2019-06-28](https://www.keypedia.com/records/483/ajanta-pharma-ltd/15e08bf4-14a3-4a50-a9be-2ac0598f15bb) — source: FDA, date: June 28, 2019
- [FDA Inspection 1097061 - Ajanta Pharma Ltd. - 2019-06-28](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/dcc8e789-9501-4bd0-9137-a7594d3fd15c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 28, 2019
- [FDA Inspection 1009806 - Ajanta Pharma Ltd. - 2017-02-07](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/37667b7f-e3eb-484d-b81a-6f18f5d14860) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 7, 2017
- [FDA Inspection 917795 - Ajanta Pharma Ltd. - 2015-03-20](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/5b1d556e-3f3c-4e3a-a01b-3694f397eeea) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 20, 2015
- [FDA Inspection 801522 - Ajanta Pharma Ltd. - 2012-09-06](https://www.keypedia.com/records/fda_inspections/ajanta-pharma-ltd/2feba6a5-e7b1-4e8e-843c-3cf9535a1b11) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 6, 2012

## Related Companies

- [Spectrum Pharmaceuticals, Inc.](https://www.keypedia.com/companies/spectrum-pharmaceuticals-inc/d2be8240-3764-497f-8d0d-fbedb45f3053)
- [Columbia Cosmetics Manufacturing, Inc.](https://www.keypedia.com/companies/columbia-cosmetics-manufacturing-inc/c6e32c25-080a-4901-8391-8716d6517687)
- [Pharbil Waltrop Gmbh](https://www.keypedia.com/companies/pharbil-waltrop-gmbh/f3455dea-04cf-4c53-ab8b-3fcddc45fb4c)
- [G S Cosmeceutical USA Inc](https://www.keypedia.com/companies/g-s-cosmeceutical-usa-inc/02e5e566-9934-4417-9659-f041ee537843)
- [Buckeye International Inc](https://www.keypedia.com/companies/buckeye-international-inc/01799cae-da24-4d86-9a28-d25a72c9bc8b)
- [McKenna Labs Inc](https://www.keypedia.com/companies/mckenna-labs-inc/a0956f9d-e7ea-4bf6-ac78-77140586f684)
- [Evi Labs](https://www.keypedia.com/companies/evi-labs/0713d12b-117d-4b0b-a25e-2df2a5682fc4)
- [Medline Industries, Inc.](https://www.keypedia.com/companies/medline-industries-inc/ab99df74-d4aa-44f4-aed8-fcb2d3e45280)
- [Hillyard GMP](https://www.keypedia.com/companies/hillyard-gmp/68d27919-f3ad-48da-a664-cf48fee3133a)
- [Dixon Investments Inc](https://www.keypedia.com/companies/dixon-investments-inc/ce191609-e6f1-4391-8f04-21996703095d)

## Related Officers

- [Jose A. Lopez-Robles](https://www.keypedia.com/people/jose-a-lopez-robles/73ed16a0-3b6f-414b-938f-e58b027c3e9b)
- [Investigator ](https://www.keypedia.com/people/nicole-e-knowlton/8e65400f-249f-45fe-96fc-cb00fec6ae39)
- [Nibin Varghese](https://www.keypedia.com/people/nibin-varghese/43e17f63-2c1f-4d46-b26f-dc8ac8885438)
- [Consumer Safety Officer - Dedicated Foreign Drug Cadre](https://www.keypedia.com/people/tamil-arasu/94efc491-7d9f-4221-a1ee-69a925acb1c3)